PortfoliosLab logo
CNP vs. ABT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CNP and ABT is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

CNP vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CenterPoint Energy, Inc. (CNP) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CNP:

1.52

ABT:

1.46

Sortino Ratio

CNP:

1.84

ABT:

2.05

Omega Ratio

CNP:

1.25

ABT:

1.26

Calmar Ratio

CNP:

1.54

ABT:

1.15

Martin Ratio

CNP:

4.75

ABT:

6.83

Ulcer Index

CNP:

6.09%

ABT:

4.30%

Daily Std Dev

CNP:

20.79%

ABT:

21.11%

Max Drawdown

CNP:

-88.40%

ABT:

-45.66%

Current Drawdown

CNP:

-2.80%

ABT:

-4.75%

Fundamentals

Market Cap

CNP:

$24.52B

ABT:

$228.44B

EPS

CNP:

$1.48

ABT:

$7.69

PE Ratio

CNP:

25.39

ABT:

17.07

PEG Ratio

CNP:

2.52

ABT:

4.17

PS Ratio

CNP:

2.74

ABT:

5.39

PB Ratio

CNP:

2.24

ABT:

4.68

Total Revenue (TTM)

CNP:

$8.94B

ABT:

$42.34B

Gross Profit (TTM)

CNP:

$4.02B

ABT:

$23.67B

EBITDA (TTM)

CNP:

$3.51B

ABT:

$11.20B

Returns By Period

In the year-to-date period, CNP achieves a 20.41% return, which is significantly higher than ABT's 18.70% return. Over the past 10 years, CNP has underperformed ABT with an annualized return of 10.10%, while ABT has yielded a comparatively higher 12.71% annualized return.


CNP

YTD

20.41%

1M

-0.61%

6M

17.45%

1Y

31.35%

3Y*

8.02%

5Y*

19.01%

10Y*

10.10%

ABT

YTD

18.70%

1M

3.17%

6M

13.82%

1Y

30.46%

3Y*

6.50%

5Y*

9.54%

10Y*

12.71%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CenterPoint Energy, Inc.

Abbott Laboratories

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

CNP vs. ABT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNP
The Risk-Adjusted Performance Rank of CNP is 8686
Overall Rank
The Sharpe Ratio Rank of CNP is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of CNP is 8383
Sortino Ratio Rank
The Omega Ratio Rank of CNP is 8383
Omega Ratio Rank
The Calmar Ratio Rank of CNP is 9090
Calmar Ratio Rank
The Martin Ratio Rank of CNP is 8585
Martin Ratio Rank

ABT
The Risk-Adjusted Performance Rank of ABT is 8787
Overall Rank
The Sharpe Ratio Rank of ABT is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of ABT is 8686
Sortino Ratio Rank
The Omega Ratio Rank of ABT is 8484
Omega Ratio Rank
The Calmar Ratio Rank of ABT is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ABT is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CNP vs. ABT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CenterPoint Energy, Inc. (CNP) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CNP Sharpe Ratio is 1.52, which is comparable to the ABT Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of CNP and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

CNP vs. ABT - Dividend Comparison

CNP's dividend yield for the trailing twelve months is around 2.25%, more than ABT's 1.72% yield.


TTM20242023202220212020201920182017201620152014
CNP
CenterPoint Energy, Inc.
2.25%2.55%2.70%2.33%2.33%3.42%4.22%3.93%3.77%4.18%5.39%4.05%
ABT
Abbott Laboratories
1.72%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%

Drawdowns

CNP vs. ABT - Drawdown Comparison

The maximum CNP drawdown since its inception was -88.40%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for CNP and ABT.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

CNP vs. ABT - Volatility Comparison

The current volatility for CenterPoint Energy, Inc. (CNP) is 5.15%, while Abbott Laboratories (ABT) has a volatility of 5.62%. This indicates that CNP experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

CNP vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between CenterPoint Energy, Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
2.92B
10.36B
(CNP) Total Revenue
(ABT) Total Revenue
Values in USD except per share items

CNP vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between CenterPoint Energy, Inc. and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

25.0%30.0%35.0%40.0%45.0%50.0%55.0%60.0%20212022202320242025
39.9%
56.9%
(CNP) Gross Margin
(ABT) Gross Margin
CNP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, CenterPoint Energy, Inc. reported a gross profit of 1.17B and revenue of 2.92B. Therefore, the gross margin over that period was 39.9%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.

CNP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, CenterPoint Energy, Inc. reported an operating income of 649.00M and revenue of 2.92B, resulting in an operating margin of 22.2%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.

CNP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, CenterPoint Energy, Inc. reported a net income of 297.00M and revenue of 2.92B, resulting in a net margin of 10.2%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.